Eric Schmidt - Chief Financial Officer at Allogene Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
ALLO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Eric Schmidt since 10/5/2023

Holdings reported by Eric Schmidt for Allogene Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 433K $4.16M $9.62 Mar 22, 2023 Direct Common Stock
Common Stock 1.15M $3.66M $3.17 Mar 22, 2023 Indirect
Common Stock 862K $2.74M $3.17 Mar 22, 2023 Direct

Transactions reported by Eric Schmidt for Allogene Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.